MDA passes on J lead advice to UK doctors:
This article was originally published in Clinica
The UK device regulator has recommended that patients implanted with Telectronics' Accufix atrial J pacemaker leads should now consider leaving them in place. The Medical Devices Agency (MDA) gave this advice to UK surgeons managing patients with the faulty leads based on advice from the Accufix Research Institute. The institute, set up in the wake of the Telectronics J lead adverse incidents in 1994, suggested in a "dear doctor" letter in November that surgeons should consider the age of the patient when considering a potentially life-threatening procedure to remove the leads. The J leads were taken off the market after lead fracture, with protrusion of the retention wire.